Construction of chimeric antigen receptor‑modified T cells targeting EpCAM and assessment of their anti‑tumor effect on cancer cells

Yan Zhou(First Affiliated Hospital of Chengdu Medical College), Xiao‐An Li(First Affiliated Hospital of Chengdu Medical College)
Molecular Medicine Reports
July 3, 2019
10.3892/mmr.2019.10460
Cited by 20

Related Papers

Loss of Perp in T Cells Promotes Resistance to Apoptosis of T Helper 17 Cells and Exacerbates the Development of Experimental Autoimmune Encephalomyelitis in Mice
|Frontiers in Immunology|2018|8